Glaukos (GKOS) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Glaukos Revenue Highlights

Latest Revenue (Y)

$383.48M

Latest Revenue (Q)

$124.12M

Main Segment (Y)

Glaucoma

Main Geography (Y)

UNITED STATES

Glaukos Revenue by Period

Glaukos Revenue by Year

Date	Revenue	Change
2024-12-31	$383.48M	21.85%
2023-12-31	$314.71M	11.26%
2022-12-31	$282.86M	-3.79%
2021-12-31	$294.01M	30.70%
2020-12-31	$224.96M	-5.07%
2019-12-31	$236.98M	30.73%
2018-12-31	$181.28M	13.83%
2017-12-31	$159.25M	39.21%
2016-12-31	$114.40M	59.55%
2015-12-31	$71.70M	57.28%
2014-12-31	$45.59M	117.64%
2013-12-31	$20.95M	762.33%
2012-12-31	$2.43M	-

Glaukos generated $383.48M in revenue during NA 2024, up 21.85% compared to the previous quarter, and up 161.82% compared to the same period a year ago.

Glaukos Revenue by Quarter

Date	Revenue	Change
2025-06-30	$124.12M	16.37%
2025-03-31	$106.66M	1.10%
2024-12-31	$105.50M	9.13%
2024-09-30	$96.67M	1.02%
2024-06-30	$95.69M	11.76%
2024-03-31	$85.62M	3.95%
2023-12-31	$82.36M	5.53%
2023-09-30	$78.05M	-2.92%
2023-06-30	$80.40M	8.80%
2023-03-31	$73.90M	3.75%
2022-12-31	$71.23M	-0.06%
2022-09-30	$71.27M	-1.95%
2022-06-30	$72.69M	7.39%
2022-03-31	$67.68M	-7.59%
2021-12-31	$73.24M	-1.97%
2021-09-30	$74.71M	-4.33%
2021-06-30	$78.09M	14.90%
2021-03-31	$67.97M	-7.19%
2020-12-31	$73.23M	12.96%
2020-09-30	$64.83M	105.43%
2020-06-30	$31.56M	-42.97%
2020-03-31	$55.34M	-15.97%
2019-12-31	$65.85M	12.55%
2019-09-30	$58.51M	-0.16%
2019-06-30	$58.60M	8.47%
2019-03-31	$54.03M	-0.09%
2018-12-31	$54.08M	23.16%
2018-09-30	$43.91M	1.73%
2018-06-30	$43.16M	7.54%
2018-03-31	$40.13M	-3.64%
2017-12-31	$41.65M	3.06%
2017-09-30	$40.41M	-2.11%
2017-06-30	$41.28M	14.98%
2017-03-31	$35.91M	8.24%
2016-12-31	$33.17M	12.15%
2016-09-30	$29.58M	3.58%
2016-06-30	$28.56M	23.66%
2016-03-31	$23.09M	13.89%
2015-12-31	$20.28M	6.69%
2015-09-30	$19.00M	7.04%
2015-06-30	$17.75M	21.06%
2015-03-31	$14.67M	3.92%
2014-12-31	$14.11M	16.39%
2014-09-30	$12.13M	9.25%
2014-06-30	$11.10M	34.55%
2014-03-31	$8.25M	-

Glaukos generated $124.12M in revenue during Q2 2025, up 16.37% compared to the previous quarter, and up 144.96% compared to the same period a year ago.

Glaukos Revenue Breakdown

Glaukos Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 19
Corneal Health	$6.02M
Glaucoma	$230.97M

Glaukos's latest annual revenue breakdown by segment (product or service), as of Dec 19: Glaucoma (97.46%), and Corneal Health (2.54%).

Quarterly Revenue by Product

Product/Service	Dec 20	Sep 20	Jun 20	Mar 20
Glaucoma	$58.36M	$51.93M	$24.95M	$44.13M
Corneal Health	$14.88M	$12.90M	$6.61M	$11.20M

Glaukos's latest quarterly revenue breakdown by segment (product or service), as of Dec 20: Glaucoma (79.68%), and Corneal Health (20.32%).

Glaukos Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Non-US	$113.39M	-	-	-	-
UNITED STATES	$270.09M	-	-	-	-
International	-	$95.31M	-	-	-
United States	-	$219.40M	$144.66M	$170.80M	-
Non Us	-	-	-	-	$45.64M
U	-	-	-	-	$133.72M

Glaukos's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (70.43%), and Non-US (29.57%).

Quarterly Revenue by Country

Country	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
Non-US	$33.60M	$31.59M	$86.73M	$26.65M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
UNITED STATES	$90.52M	$75.07M	$200.08M	$70.02M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
United States	-	-	-	-	$66.82M	$57.69M	$144.69M	$39.60M	$35.11M	$35.35M	$37.21M	$38.20M	$33.90M	$41.21M	-	-	-	-	-	-
International	-	-	-	-	$28.87M	$27.93M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non Us	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$15.10M	$16.41M	$13.81M	$16.30M	$14.23M	$7.39M
U	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$43.38M	$46.31M	$39.89M	$56.93M	$50.60M	$24.17M

Glaukos's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (72.93%), and Non-US (27.07%).

Glaukos Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
OSCR	Oscar Health	$9.18B	$2.86B
BLCO	Bausch + Lomb	$4.77B	$1.27B
BRKR	Bruker	$3.37B	$797.40M
ITGR	Integer	$1.72B	$467.69M
MMSI	Merit Medical Systems	$1.30B	$382.46M
IRTC	iRhythm	$591.84M	$186.69M
TMDX	TransMedics Group	$441.54M	$157.37M
GKOS	Glaukos	$383.48M	$124.12M
ACLX	Arcellx	$107.94M	$8.13M
ARWR	Arrowhead Pharmaceuticals	$3.55M	$542.71M
PTGX	Protagonist Therapeutics	-	$28.32M

GKOS Revenue FAQ

What is Glaukos’s yearly revenue?

Glaukos's yearly revenue for 2024 was $383.48M, representing an increase of 21.85% compared to 2023. The company's yearly revenue for 2023 was $314.71M, representing an increase of 11.26% compared to 2022. GKOS's yearly revenue for 2022 was $282.86M, representing a decrease of -3.79% compared to 2021.

What is Glaukos’s quarterly revenue?

Glaukos's quarterly revenue for Q2 2025 was $124.12M, a 16.37% increase from the previous quarter (Q1 2025), and a 29.71% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $106.66M, a 1.10% increase from the previous quarter (Q4 2024), and a 24.58% increase year-over-year (Q1 2024). GKOS's quarterly revenue for Q4 2024 was $105.5M, a 9.13% increase from the previous quarter (Q3 2024), and a 28.09% increase year-over-year (Q4 2023).

What is Glaukos’s revenue growth rate?

Glaukos's revenue growth rate for the last 3 years (2022-2024) was 35.57%, and for the last 5 years (2020-2024) was 70.47%.

What are Glaukos’s revenue streams?

Glaukos's revenue streams in c 19 are Corneal Health, and Glaucoma. Corneal Health generated $6.02M in revenue, accounting 2.54% of the company's total revenue Glaucoma generated $230.97M in revenue, accounting 97.46% of the company's total revenue

What is Glaukos’s main source of revenue?

For the fiscal year ending Dec 19, the largest source of revenue of Glaukos was Glaucoma. This segment made a revenue of $230.97M, representing 97.46% of the company's total revenue.